Skip to main content

Table 1 Preoperative characteristics of patients with synchronous CRLM and selected for a reverse strategy

From: Tumor response and outcome after reverse treatment for patients with synchronous colorectal liver metastasis: a cohort study

  

N = 44

 

Age (y, median)

 

63

Range 23–78

Gender (M: F)

 

28: 16

 

Primary tumor location

Colon

25

57%

 

Rectum

19

43%

Number of CRLM (median)

 

5

Range 1–30

Bilobar liver disease

 

30

68%

Size of largest CRLM (mm, median)

 

50

Range 9–151

Initial CEA (μg/l, median)

 

24.8

Range 0.6–1300

  1. CRLM colorectal liver metastasis; CEA carcinoembryonic antigen.